Racial Differences in the Effect of a Telephone-Delivered Hypertension Disease Management Program.
dc.contributor.author | Jackson, GL | |
dc.contributor.author | Oddone, EZ | |
dc.contributor.author | Olsen, MK | |
dc.contributor.author | Powers, BJ | |
dc.contributor.author | Grubber, JM | |
dc.contributor.author | McCant, F | |
dc.contributor.author | Bosworth, HB | |
dc.date.accessioned | 2024-02-01T16:51:36Z | |
dc.date.available | 2024-02-01T16:51:36Z | |
dc.date.issued | 2012-08 | |
dc.description.abstract | BACKGROUND: African Americans are significantly more likely than whites to have uncontrolled hypertension, contributing to significant disparities in cardiovascular disease and events. OBJECTIVE: The goal of this study was to examine whether there were differences in change in blood pressure (BP) for African American and non-Hispanic white patients in response to a medication management and tailored nurse-delivered telephone behavioral program. PARTICIPANTS: Five hundred and seventy-three patients (284 African American and 289 non-Hispanic white) primary care patients who participated in the Hypertension Intervention Nurse Telemedicine Study (HINTS) clinical trial. INTERVENTIONS: Study arms included: 1) nurse-administered, physician-directed medication management intervention, utilizing a validated clinical decision support system; 2) nurse-administered, behavioral management intervention; 3) combined behavioral management and medication management intervention; and 4) usual care. All interventions were activated based on poorly controlled home BP values. MAIN MEASURES: Post-hoc analysis of change in systolic and diastolic blood pressure. General linear models (PROC MIXED in SAS, version 9.2) were used to estimate predicted means at 6-month, 12-month, and 18-month time points, by intervention arm and race subgroups (separate models for systolic and diastolic blood pressure). KEY RESULTS: Improvement in mean systolic blood pressure post-baseline was greater for African American patients in the combined intervention, compared to African American patients in usual care, at 12 months (6.6 mmHg; 95 % CI: -12.5, -0.7; p = 0.03) and at 18 months (9.7 mmHg; -16.0, -3.4; p = 0.003). At 18 months, mean diastolic BP was 4.8 mmHg lower (95 % CI: -8.5, -1.0; p = 0.01) among African American patients in the combined intervention arm, compared to African American patients in usual care. There were no analogous differences for non-Hispanic white patients. CONCLUSIONS: The combination of home BP monitoring, remote medication management, and telephone tailored behavioral self-management appears to be particularly effective for improving BP among African Americans. The effect was not seen among non-Hispanic white patients. | |
dc.identifier.issn | 1525-1497 | |
dc.identifier.issn | 1525-1497 | |
dc.identifier.uri | ||
dc.language | English | |
dc.publisher | Springer Science and Business Media LLC | |
dc.relation.ispartof | Journal of general internal medicine | |
dc.relation.isversionof | 10.1007/s11606-012-2138-x | |
dc.rights.uri | ||
dc.subject | Humans | |
dc.subject | Hypertension | |
dc.subject | Antihypertensive Agents | |
dc.subject | Blood Pressure Determination | |
dc.subject | Treatment Outcome | |
dc.subject | Severity of Illness Index | |
dc.subject | Confidence Intervals | |
dc.subject | Risk Assessment | |
dc.subject | Program Evaluation | |
dc.subject | Behavior Therapy | |
dc.subject | Telemedicine | |
dc.subject | Telecommunications | |
dc.subject | Telephone | |
dc.subject | Aged | |
dc.subject | Middle Aged | |
dc.subject | Disease Management | |
dc.subject | North Carolina | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | Medication Therapy Management | |
dc.subject | White People | |
dc.subject | Black or African American | |
dc.title | Racial Differences in the Effect of a Telephone-Delivered Hypertension Disease Management Program. | |
dc.type | Journal article | |
duke.contributor.orcid | Olsen, MK|0000-0002-9540-2103 | |
duke.contributor.orcid | Bosworth, HB|0000-0001-6188-9825 | |
pubs.begin-page | 1682 | |
pubs.end-page | 1689 | |
pubs.issue | 12 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Biostatistics & Bioinformatics | |
pubs.organisational-group | Family Medicine and Community Health | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Psychiatry & Behavioral Sciences | |
pubs.organisational-group | Medicine, General Internal Medicine | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Center for the Study of Aging and Human Development | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Duke Science & Society | |
pubs.organisational-group | Population Health Sciences | |
pubs.organisational-group | Duke Innovation & Entrepreneurship | |
pubs.organisational-group | Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences | |
pubs.organisational-group | Duke - Margolis Center For Health Policy | |
pubs.organisational-group | Biostatistics & Bioinformatics, Division of Biostatistics | |
pubs.publication-status | Published | |
pubs.volume | 27 |